Human macrophage immunophenotype modulated by biomaterial-encapsulated MSC

生物材料封装的 MSC 调节人巨噬细胞免疫表型

基本信息

批准号：
8714037
负责人：
WEIYUAN J KAO
金额：
$ 21.72万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-08-01 至 2016-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8714037
关键词：
3-Dimensional Accounting Acute Adult Allogenic Animal Model Anti-Inflammatory Agents Anti-inflammatory Antigen Presentation Beds Biocompatible Materials Biomechanics Blood Bone Marrow Cardiovascular Diseases Cell Fate Control Cell Therapy Cell Transplantation Cell physiology Cells Chemicals Chronic Clinic Clinical Clinical Research Coculture Techniques Collaborations Cutaneous Development Disadvantaged Disease Encapsulated Ethics Event Foreign-Body Reaction Goals Healed Hematopathology Hemostatic function Histocompatibility Testing Human Hydrogels Immune response Immunophenotyping Immunosuppressive Agents Impaired wound healing In Vitro Inflammation Inflammatory Injury Interleukins Knowledge Mediating Mediator of activation protein Mesenchymal Modeling Molecular Myocardial Infarction Pathology Pharmaceutical Preparations Phase Phenotype Platelet-Derived Growth Factor Process Property Proteins Recruitment Activity Refractory Regenerative Medicine Research Role Spinal cord injury Staging Stromal Cells Surface Tissue Engineering Tissues Translating Validation Vascular Endothelial Growth Factors Work Wound Healing age related analytical method base design embryonic stem cell graft vs host disease healing implantation improved in vivo loss of function macrophage monocyte pre-clinical public health relevance stem cell therapy tissue regeneration wound

项目摘要

DESCRIPTION (provided by applicant): Adult tissue-derived mesenchymal stromal cells (MSC) have demonstrated promise in treating various pathologies including myocardial infarction, graft versus host disease and other tissue injuries such refractory wounds. Much of current work on MSC-based therapies consists of the development of cell entrapment matrix to control cell function and fate after implantation. While MSC had shown to have immunomodulatory properties, the impact of the MSC-encapsulated biomatrix on the host macrophage immunophenotype and host foreign body reaction is less clear. We hypothesize that adult, human bone marrow-derived MSC (BM- MSC) that are encapsulated into a 3-D biomaterial will preferentially modulate the polarization of host primary macrophages from a pro-inflammatory state towards a pro-healing and anti-inflammatory phenotype. A clear understanding of this three-way interaction between encapsulated MSC, macrophages, and biomaterial using primary human cells is required for the development of effective MSC-hydrogel strategies in cell-based regenerative medicine. To achieve this, we will: (1) formulate well-characterized biomaterials with improved biomechanic properties including strength and lack of contraction over commercially-available cell-delivery matrices for BM-MSC encapsulation; (2) assess the immunophenotype of blood-derived primary macrophages as modulated by biomaterial-entrapped BM-MSC in 3-D co-cultures; (3) confirm the ability of 3-D biomaterial- entrapped BM-MSC to recruit and modulate macrophage pro-healing phenotype in a wound model.

描述（由申请人提供）：成人组织衍生的间充质基质细胞（MSC）在治疗各种病理学方面表现出了希望，包括心肌梗塞，移植物与宿主疾病和其他组织损伤。当前基于MSC的疗法的许多工作包括开发细胞夹层矩阵以控制植入后细胞功能和命运。虽然MSC已证明具有免疫调节特性，但MSC封装的Biomatrix对宿主巨噬细胞免疫表型和宿主异物反应的影响尚不清楚。我们假设封装在3-D生物材料中的成年人骨髓衍生的MSC（BM-MSC）将优先调节宿主原代巨噬细胞的极化，从促炎性状态到促疾病和抗炎表型。在基于细胞的再生医学中开发有效的MSC杂凝策略，需要对使用原代人类细胞的封装MSC，巨噬细胞和生物材料之间的这种三向相互作用的清晰了解。为此，我们将：（1）制定具有改进生物力学特性的特征良好的生物材料，包括强度和对BM-MSC封装的商业可用细胞递送矩阵缺乏收缩；（2）评估3-D共培养中生物材料置换的BM-MSC调节血液衍生的原发性巨噬细胞的免疫表型；（3）确认3-D生物材料夹住的BM-MSC能够在伤口模型中募集和调节巨噬细胞pro-Healing表型。